Rupix

Symbiotec Pharmalab IPO subscription status

The Symbiotec Pharmalab IPO was subscribed 75.06 times in total when bidding closed on 27 August 2026. By category: qualified institutional buyers 172.03 times, non-institutional investors 73.63 times, retail investors 12.96 times. The issue closed oversubscribed, so allotment in the oversubscribed categories was by lottery for retail and proportionate for institutions and non-institutional investors.

Subscription at a glance

Total
75.06 times
QIB
172.03 times
NII
73.63 times
Retail
12.96 times
Bidding
24 August 2026 to 27 August 2026
Figures as of
27 August 2026
Price band
₹938 to ₹988
Lot size
15 shares

Shares offered and bid, by category

CategoryShares offeredShares bidTimes
Retail65,44,776—12.96×
NII28,04,904—73.63×
QIB37,39,872—172.03×

Cumulative bids from the BSE and NSE public-issue platforms. The anchor portion is allotted the day before the issue opens and is not part of the book.

Day by day

DayRetailQIBbHNIsHNITotalNII
Day 1 (24 August 2026)1.00×0.37×0.82×1.66×0.85×1.10×
Day 2 (25 August 2026)2.21×0.57×2.59×4.30×1.95×3.16×
Day 3 (26 August 2026)5.33×0.62×11.90×14.72×5.60×12.84×
Day 4 (27 August 2026)13.65×181.20×87.34×58.01×75.06×77.56×
Day 5 (28 August 2026)13.65×181.20×87.34×58.01×75.06×77.56×

What the figures mean for allotment

Retail was subscribed about 12.96 times, so roughly one in 13 retail applicants received a lot, by lottery, each successful applicant getting exactly one lot. Non-institutional allotment was proportionate at 73.63 times: an applicant for 736 lots received about ten, and the minimum allotment is the category's minimum application.

Check the Symbiotec Pharmalab IPO allotment status

Questions about the Symbiotec Pharmalab IPO subscription

What was the subscription status of the Symbiotec Pharmalab IPO?

75.06 times overall: QIB 172.03 times, NII 73.63 times, retail 12.96 times. The figure is the shares bid for divided by the shares offered in that category, from the exchanges' cumulative bid data.

Was the Symbiotec Pharmalab IPO oversubscribed?

Yes, 75.06 times overall, and 12.96 times in retail. Above one time, applicants in that category are not guaranteed shares.

What were the chances of a retail allotment in the Symbiotec Pharmalab IPO?

Retail was subscribed about 12.96 times, so roughly one in 13 retail applicants received a lot, by lottery, each successful applicant getting exactly one lot.

What do QIB, NII and retail mean in the Symbiotec Pharmalab IPO subscription?

Qualified institutional buyers are mutual funds, insurers, banks and foreign institutions. Non-institutional investors, also called HNI, are individuals and bodies bidding above two lakh rupees, split into small (two to ten lakh) and big (above ten lakh). Retail is an individual bidding up to two lakh rupees. A book-built mainboard issue sets aside at least 35 percent for retail, 15 percent for NII and up to 50 percent for QIBs.

Does a high subscription mean the Symbiotec Pharmalab IPO will list at a premium?

No. Subscription measures demand during the three bidding days; the listing price is discovered in the pre-open session on listing morning and depends on the market that day. Heavily subscribed issues have listed at a discount and thin ones at a premium. Read the figure with the expected premium and the company's numbers, not instead of them.

When was the Symbiotec Pharmalab IPO allotment?

28 August 2026. The allotment status is searchable by PAN on Rupix and on the registrar's page from that evening.